TOP2A and hepatocellular carcinoma: The hub genes identified, especially CCNA2, CCNB2, CDK1, and TOP2A, represent promising biomarker candidates and potential therapeutic targets worthy of further investigation for improving early HCC detection and treatment outcomes.